Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

27 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma.
Zaretsky JM, Garcia-Diaz A, Shin DS, Escuin-Ordinas H, Hugo W, Hu-Lieskovan S, Torrejon DY, Abril-Rodriguez G, Sandoval S, Barthly L, Saco J, Homet Moreno B, Mezzadra R, Chmielowski B, Ruchalski K, Shintaku IP, Sanchez PJ, Puig-Saus C, Cherry G, Seja E, Kong X, Pang J, Berent-Maoz B, Comin-Anduix B, Graeber TG, Tumeh PC, Schumacher TN, Lo RS, Ribas A. Zaretsky JM, et al. Among authors: ruchalski k. N Engl J Med. 2016 Sep 1;375(9):819-29. doi: 10.1056/NEJMoa1604958. Epub 2016 Jul 13. N Engl J Med. 2016. PMID: 27433843 Free PMC article.
Tunable-combinatorial mechanisms of acquired resistance limit the efficacy of BRAF/MEK cotargeting but result in melanoma drug addiction.
Moriceau G, Hugo W, Hong A, Shi H, Kong X, Yu CC, Koya RC, Samatar AA, Khanlou N, Braun J, Ruchalski K, Seifert H, Larkin J, Dahlman KB, Johnson DB, Algazi A, Sosman JA, Ribas A, Lo RS. Moriceau G, et al. Among authors: ruchalski k. Cancer Cell. 2015 Feb 9;27(2):240-56. doi: 10.1016/j.ccell.2014.11.018. Epub 2015 Jan 15. Cancer Cell. 2015. PMID: 25600339 Free PMC article.
Feasibility and Safety of Intrathoracic Biopsy and Repeat Biopsy for Evaluation of Programmed Cell Death Ligand-1 Expression for Immunotherapy in Non-Small Cell Lung Cancer.
Tsai EB, Pomykala K, Ruchalski K, Genshaft S, Abtin F, Gutierrez A, Kim HJ, Li A, Adame C, Jalalian A, Wolf B, Garon EB, Goldman JW, Suh R. Tsai EB, et al. Among authors: ruchalski k. Radiology. 2018 Apr;287(1):326-332. doi: 10.1148/radiol.2017170347. Epub 2017 Dec 12. Radiology. 2018. PMID: 29232184 Free PMC article.
The evidence for low-dose CT screening of lung cancer.
Ruchalski K, Gutierrez A, Genshaft S, Abtin F, Suh R. Ruchalski K, et al. Clin Imaging. 2016 Mar-Apr;40(2):288-95. doi: 10.1016/j.clinimag.2015.07.001. Epub 2015 Jul 17. Clin Imaging. 2016. PMID: 26362352 Review.
A Primer on RECIST 1.1 for Oncologic Imaging in Clinical Drug Trials.
Ruchalski K, Braschi-Amirfarzan M, Douek M, Sai V, Gutierrez A, Dewan R, Goldin J. Ruchalski K, et al. Radiol Imaging Cancer. 2021 May;3(3):e210008. doi: 10.1148/rycan.2021210008. Radiol Imaging Cancer. 2021. PMID: 33988475 Free PMC article.
Lung Cancer Screening Update.
Ruchalski KL, Brown K. Ruchalski KL, et al. J Thorac Imaging. 2016 Jul;31(4):190-200. doi: 10.1097/RTI.0000000000000221. J Thorac Imaging. 2016. PMID: 27306387 Review.
27 results